The Pseudomonas aeruginosa phoP-phoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3122-3131

  Gellatly, Shaan L ^a   Needham, Brittany ^b   Madera, Laurence ^a   Trent, M Stephen ^b   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PROTEINASE; TRIACYLGLYCEROL LIPASE;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COCULTURE; CYTOTOXICITY; GENE MUTATION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM; UPREGULATION; VIRULENCE; WILD TYPE;

BACTERIAL ADHESION; BACTERIAL PROTEINS; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 84867600336     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00382-12     Document Type: Article

References (67)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783- 801.
2. Alexander C, Rietschel ET. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:167-202.
3. Bader MW, et al. 2005. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122:461- 472.
4. Barrow K, Kwon DH. 2009. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:5150 -5154.
5. Bazzoni F, Tamassia N, Rossato M, Cassatella MA. 2010. Understanding the molecular mechanisms of the multifaceted IL-10-mediated antiinflammatory response: lessons from neutrophils. Eur. J. Immunol. 40: 2360-2368.
6. Bleves S, et al. 2010. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int. J. Med. Microbiol. 300:534- 543.
7. Bozue J, et al. 2011. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microb. Pathog. 50:314 -321.
8. Bragonzi A, et al. 2009. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am. J. Respir. Crit. Care Med. 180:138 -145.
9. Chastre J, Fagon J. 2002. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165:867-903.
10. Chugani S, Greenberg EP. 2007. The influence of human respiratory epithelia on Pseudomonas aeruginosa gene expression. Microb. Pathog. 42:29 -35.
11. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Høiby N. 2010. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156:1108 -1119.
12. Darveau RP, Hancock REW. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831- 838.
13. Davies JC. 2002. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr. Respir. Rev. 3:128 -134.
14. de Kievit TR, Iglewski BH. 2000. Bacterial quorum sensing in pathogenic relationships. Infect. Immun. 68:4839-4849.
15. Ernst RK, et al. 1999. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561-1565.
16. Ernst RK, et al. 2006. The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J. Bacteriol. 188:191-201.
17. Ernst RK, et al. 2007. Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J. Infect. Dis. 196:1088 -1092.
18. Fleiszig SM, Evans DJ. 2002. The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin. Exp. Optom. 85:271-278.
19. Folch J, Lees M, Stanley GHS. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
20. Furutani T, Su R, Ooshima H, Kato J. 1995. Simple screening method for lipase for transesterification in organic solvent. Enzyme Microb. Technol. 17:1067-1072.
21. Gooderham WJ, et al. 2009. The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 155:699 -711.
22. Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB. 2004. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect. Immun. 72:4973- 4984.
23. Groisman EA. 2001. The pleiotropic two-component regulatory system PhoP-PhoQ. J. Bacteriol. 183:1835-1842.
24. Gunn JS, et al. 1998. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27:1171-1182.
25. Hancock RE, et al. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypeable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:170 -177.
26. Hankins JV, Trent MS. 2009. Secondary acylation of Vibrio cholerae lipopolysaccharide requires phosphorylation of Kdo. J. Biol. Chem. 284: 25804-25812.
27. Hauser AR, et al. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
28. Hite RD. 2002. Surfactant deficiency in adults. Clin. Pulm. Med. 9:39-45.
29. Hobden JA. 2002. Pseudomonas aeruginosa proteases and corneal virulence. DNA Cell Biol. 21:391-396.
30. Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562.
31. Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Hoiby N. 2008. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J. Cyst. Fibros. 7:391- 397.
32. Kato A, Groisman EA. 2008. The PhoQ/PhoP regulatory network of Salmonella enterica. Adv. Exp. Med. Biol. 631:7-21.
33. King JD, Kocincova D, Westman EL, Lam JS. 2009. Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun. 15:261-312.
34. Kipnis E, Sawa T, Wiener-Kronish J. 2006. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med. Mal. Infect. 36:78 -91.
35. Kuang Z, et al. 2011. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein A. PLoS One 6:e27091. doi:10.1371/journal.pone.0027091.
36. Lee VT, Smith RS, Tummler B, Lory S. 2005. Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection. Infect. Immun. 73:1695-1705.
37. Llama-Palacios A, Lopez-Solanilla E, Rodriguez-Palenzuela P. 2005. Role of the PhoP-PhoQ system in the virulence of Erwinia chrysanthemi strain 3937: involvement in sensitivity to plant antimicrobial peptides, survival at acid pH, and regulation of pectolytic enzymes. J. Bacteriol. 187:2157-2162.
38. Macfarlane ELA, Kwasnicka A, Ochs MM, Hancock REW. 1999. PhoPPhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
39. Macfarlane EL, Kwasnicka A, Hancock RE. 2000. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
40. Malloy JL, Veldhuizen RA, Thibodeaux BA, O'Callaghan RJ, Wright JR. 2005. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L409 -L418.
41. Matsumoto K. 2004. Role of bacterial proteases in pseudomonal and serratial keratitis. Biol. Chem. 385:1007-1016.
42. Mena A, et al. 2008. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190:7910 -7917.
43. Miller AK, et al. 2011. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother. 55:5761-5769.
44. Miller SI, Kukral AM, Mekalanos JJ. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. U. S. A. 86:5054 -5058.
45. Mookherjee N, et al. 2006. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176:2455-2464.
46. Moskowitz SM, Ernst RK. 2010. The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection. Subcell. Biochem. 53:241-253.
47. Moskowitz SM, et al. 2010. Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 65:1416 -1423.
48. Muir A, et al. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30:777-783.
49. Osborn MJ. 1963. Studies on Gram-negative cell wall. 1. Evidence for role of 2-keto-3 deoxyoctonate in lipopolysaccharide of Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 50:499 -506.
50. Oyston PCF, et al. 2000. The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect. Immun. 68:3419 -3425.
51. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087.
52. Peterson AA, Haug A, McGroarty EJ. 1986. Physical properties of shortand long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J. Bacteriol. 165:116 -122.
53. Pistolic J, et al. 2009. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-B signaling pathway. J. Innate Immun. 1:254 -267.
54. Prost LR, Miller SI. 2008. The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals. Cell. Microbiol. 10:576 -582.
55. Sadikot RT, Blackwell TS, Christman JW, Prince AS. 2005. Pathogenhost interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171:1209 -1223.
56. Schaber JA, et al. 2004. Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 53:841- 853.
57. Schurek KN, et al. 2009. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 4345-4351.
58. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. 2004. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31:358 -364.
59. Smith EE, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103: 8487-8492.
60. Son MS, Matthews WJ, Jr, Kang Y, Nguyen DT, Hoang TT. 2007. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75:5313- 5324.
61. Sriramulu DD, Nimtz M, Romling U. 2005. Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment. Proteomics 5:3712-3721.
62. Stepinska M, Trafny EA. 2008. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. Microb. Pathog. 44:448-458.
63. Teghanemt A, Zhang D, Levis EN, Weiss JP, Gioannini TL. 2005. Molecular basis of reduced potency of underacylated endotoxins. J. Immunol. 175:4669-4676.
64. Wei Q, et al. 2011. Phenotypic and genome-wide analysis of an antibioticresistant small colony variant (SCV) of Pseudomonas aeruginosa. PLoS One 6:e29276. doi:10.1371/journal.pone.0029276.
65. Wolfgang MC, et al. 2003. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:8484-8489.
66. Yang L, Jelsbak L, Molin S. 2011. Microbial ecology and adaptation in cystic fibrosis airways. Environ. Microbiol. 13:1682-1689.
67. Zhou Z, Lin S, Cotter RJ, Raetz CR. 1999. Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K-12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. J. Biol. Chem. 274:18503-18514.